The integration of drugs with nanomaterials have received significant interest in the efficient drug delivery systems. Conventional treatments with therapeutically active drugs may cause undesired side effects and thus, novel strategies to perform these treatments with a combinatorial approach of therapeutic modalities are required. In this study, polymethacrylic acid coated gold nanoparticles (AuNP-PMAA) which were synthesized with reversible addition-fragmentation chain transfer (RAFT) polymerization were combined with doxorubicin (DOX) as a model anticancer drug by creating a pH-sensitive hydrazone linkage in the presence of cysteine (Cys) and a cross-linker. Drug-AuNP conjugates were characterized via spectrofluorimetry, dynamic light scattering and zeta potential measurements as well as X-ray photoelectron spectroscopy. The particle size of AuNP-PMAA and AuNP-PMAA-Cys-DOX conjugate were calculated as found as 104 nm and 147 nm, respectively. Further experiments with different pH conditions (pH 5.3 and 7.4) also showed that AuNP-PMAA-Cys-DOX conjugate could release the DOX in a pH-sensitive way. Finally, cell culture applications with Human cervix adenocarcinoma cell line (HeLa cells) demonstrated effective therapeutic impact of the final conjugate for both chemotherapy and radiation therapy by comparing free DOX and AuNP-PMAA independently. Moreover, cell imaging study was also an evidence that AuNP-PMAA-Cys-DOX could be a beneficial candidate as a diagnostic agent.
INTRODUCTION
Recently, the use of nanomaterials in drug delivery systems has gained a tremendous attraction in the research of the pharmaceutical industry. 1 Their usage in drug formulations is getting more important due to the limitation by poor penetration of drugs into tumor tissues and adverse effects on healthy cells. Since the conventional therapies including therapeutically active drug molecule may not generate a selective distribution for a certain location on the organism, undesirable impacts could have been observed in organs and healthy tissues. In order to prevent side effects, surface modification strategies become crucial because the attachment of targeting moieties to the drug carrier system makes it selective to the target tissue or cells. 2, 3 There are two strategies for obtaining the targeted drug delivery; (i) passive targeting and (ii) active targeting. Passive targeting includes the transport of the nanocarriers, though leaky vasculature of the diseased tissues via convection or passive diffusion and this technique reveals the enhanced permeability and retention (EPR) effect of the drug carrier systems. 4, 5 The use of passive targeting may cause the accumulation of the nanocarriers within long circulation time in solid tumors. 6 For being the appropriate candidate to use in passive targeting with EPR effect, the nano-carriers should include three important
properties; first, they should be larger than 10 nm to avoid the filtration by the kidneys and should be about 100 nm to avoid the specific capture by the liver. Second, the nano-carriers should be non-ionic or anionic in order to avoid the renal elimination. Third, they should be recognized by the reticuloendothelial system for not to be phagocytosed. 7 Within this strategy, many drug delivery systems have been reported, especially with the use of metallic nanoparticles, polymers, lipid or surfactant based vesicular carriers. [8] [9] [10] [11] [12] Active targeting of nanoparticles contains peripherally conjugated targeting ligands for enhanced and selective delivery. The targeting ligands such as antibodies, folic acid, glycoconjugates or nucleic acids like aptamers are important to the mechanism of cellular uptake. Long circulation times will 4 allow for effective transport of the nanoparticles to the tumor site through the EPR effect, and the targeting molecule is able to increase endocytosis of the nanoparticles. The internalization of nanoparticle drug delivery systems has shown an increased therapeutic effect. 13, 14 Those drug delivery systems have been generally constructed for the cancer treatment which remains the major common cause of morbidity and mortality throughout the world. 15 In the treatment of cancers, a combination of several types of therapeutic modalities with distinct mechanisms is considered to be a potential strategy. 16 Chemotherapy is one of the most common therapies employed in oncology. Therefore, newly designed drug delivery systems are regarded as a new paradigm in cancer chemotherapy, particularly by creating pH-sensitive infrastructures thanks to the feature of lower acidic matrix of cancerous tissue. 17 By using this prominent information, numerous chemotherapeutic strategies were developed involving a pH-dependent conjugation approach. [18] [19] [20] Concomitantly, novel multifunctional carriers also offer combinatorial therapies with this approach. In a related study, Chen et al. designed a novel kind of intelligent nanogels which can spatiotemporally control the release of doxorubicin and photosensitizers to combine chemotherapy and photodynamic therapy. 21 Gold nanoparticles (AuNPs) are emerging as an efficient platform for diagnostic and therapeutic purposes since they have several unique features such as chemical inertness, facile surface functionalizability, electronic structure amenable for plasmon resonance and optical properties suitable as imaging agents. 22 On the other hand, in spite of the synthesis of AuNPs is well-advanced, sometimes colloidal stability of NPs might create aggregation problems in the case of long-term stability. Furthermore, AuNPs are known as nontoxic, however, AuNPs with the size of 1.4 nm induced the toxicity of HeLa cells to a greater extent rather than 15 nm AuNPs. 23 Meanwhile, toxicity of colloidal NPs is also due to the surface chemistry. In regard of this situation, it has to be essential to control precisely the functional groups on the surface as well as remove residual contaminants, especially citrate, arising from the particle 5 synthesis. [24] [25] [26] (Z = 6), gadolinium (Z = 64), and platinum (Z = 78) due to the photoelectric effect of gold. 32 Also, PEG, polysaccharides, poloxamines or poloxamers covered AuNPs were introduced to radiation therapy. 33 Herein, a combined nanoplatform involving both polymethacrylic acid coated AuNPs (AuNP-PMAA) and an anti-cancer drug doxorubicin (DOX) was synthesized with a pHsensitive hydrazone linkage between cysteine (Cys) modified AuNP-PMAA and DOX.
Following the succesful preparation of DOX conjugated AuNP which was denoted as "AuNP-PMAA-Cys-DOX", spectroscopic and physicochemical characterizations and in vitro drug release studies were accomplished. AuNP-PMAA-Cys-DOX conjugates were applied for the further cell culture studies including cytotoxicity, radiotherapy and cell imaging by using increase at 30 °C/min to 300 °C (hold for 2.5 min). The injector was operated at 250 °C and the FID was operated at 320 °C. Nitrogen was used as carrier gas at flow rate of 6.5 mL/min and a split ratio of 1:1 was applied. Chromatographic data was processed using OpenLab CDS ChemStation Edition, version C.01.05.
Thermal Gravimetric Analysis (TGA) was conducted with a TA Instruments TGA Q500 under nitrogen atmosphere using approximately 5.0 mg of the respective sample for the analysis. Method settings: heating from 100 to 900 °C with a heating rate of 10 °C/min. UV measurements were performed on a PerkinElmer UV/Vis Spectrometer Lambda 35.
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Transmission Electron Microscopy (TEM) analysis was carried out on a JEOL 1400 instrument operating at an acceleration voltage 200 kV. The TEM specimens were made by placing a drop of a nanoparticle water suspension on a carbon-coated copper grid.
Spectrofluorimetric and X-ray photoelectron spectroscopy (XPS) analysis were carried out to confirm the conjugation of AuNP-PMAA particles to DOX, particle size, surface charge. Size distribution and zeta potential of AuNP-PMAA-Cys-DOX conjugates were measured by a dynamic light scattering (DLS) method with Zetasizer Nano ZS (Malvern Instruments Ltd., U.K.) at a scattering angle of 90 using a wavelength of 633 nm and at 25 °C.
Prior to measurements, the samples (50 µL) were diluted to 1.0 mL with PBS and each sample was measured three times. Zeta potential of samples was calculated by the device according to Smoluchowski equation. The samples were kept in +4 °C when not in use. The samples of AuNP-PMAA, DOX and AuNP-PMAA-Cys-DOX with varying concentrations were added to wells and then the cell culture plates were placed in a CO 2 incubator for incubation at 37 °C for 2 h. After incubation, the cells were washed to remove culture medium. MTT assay on the cell lines was carried out according to standard procedure.
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The dose-dependent cell viability of bioconjugates was reported as cell viabilities relative to the control (untreated) cells. The disappearance of the aromatic protons of the RAFT agent at 7.8-7.9 ppm after being treated indicated that all end groups in the CPDB units have been reduced. As depicted in As seen in Figure 3 , the position of the SPR max band shifted from 519 to 521 nm due to adsorption of PMAA on the surface. Moreover, UV absorbance peak confirmed that the AuNPs coated with thiol-terminated PMAA were still spherical in shape and also did not show any aggregation due to not any large broad shift in the UV absorbance.
PMAA-Substituted GNPs were characterized in terms of the size and zeta potential by using DLS. There was a significant increase in the hydrodynamic volume between AuNPs and PMAA-AuNP, indicating successful immobilization of PMAA onto the surface. As depicted in Figure 2 , the size of the gold nanoparticles after the coating with PMAA increased As the initial characterization step of AuNP-PMAA-Cys-DOX conjugate, the spectrophotometric properties were investigated. The fluorescence and UV-vis spectra of conjugate were illustrated in Figure 4 . To compare the spectral features of DOX before and after conjugation procedure, free DOX was also used at the same concentration in AuNP-PMAA-Cys-DOX conjugate. As revealed in Figure 4A , DOX could show its fluorescence emission at 600 nm (ex: 480 nm) while it was conjugated to AuNP-PMAA-Cys. Herein, the DOX conjugation was proved with the decrease of fluorescence intensity and absorption peaks which was caused by the conjugation steps. In the other studies, similar cases showed up as demonstrated in Du et al. 34 and Shantni et al. 35 by conjugation of polymer-quantum dots and PEGylated palladium nanoparticles. However, DOX could protect its spectral properties After the spectroscopic characterization of AuNP-PMAA-Cys-DOX conjugate, another physicochemical parameter was investigated in terms of particle size and zeta potential ( Figure 4B and 4C). The hydrodynamic particle sizes of AuNP-PMAA and AuNP-PMAA-Cys-DOX were assessed as 104±0.7 nm (polydispersity index (PDI): 0.15) and 147±25 nm (PDI: 0.43), respectively. According to the subsequent zeta potential analysis, the 20 surface charges of AuNP-PMAA and AuNP-PMAA-Cys-DOX were assessed as -43.6±0.8 mV and -22.7±12 mV, respectively. Expectedly, the hydrodynamic particle size of AuNP-PMAA was increased after the DOX conjugation. Moreover, the negative surface charge formed from the -COOH side groups of PMAA was decreased by covering the surface with Cys and DOX. It is known that negatively surface charged NPs demonstrate a reduced plasma protein adsorption and low rate of nonspecific cellular uptake. 36, 37 Additionally, the charged NPs can repel one another to overcome the natural tendency of aggregation of NPs. 38 Hence, it can be claimed that newly synthesized AuNP-PMAA and their DOX conjugated forms could be suitable for the accumulation in the cancerous tissue by EPR effect thanks to their good dispersion stability which was supported by PDI values.
In addition to the physicochemical parameters, XPS of the AuNP-PMAA-Cys-DOX was employed to observe the demand typical bonds of the final conjugate via the binding energies. XPS spectrum in Figure 5 illustrates the detailed information about the crucial bonds which were used in the conjugation steps, including an amide bond between carboxyl residues of AuNP-PMAA and amino group of Cys and hydrazone as the pH-sensitive linkage. In the spectra, the binding energy of 282.65 eV reveals the typical C-C bonds. Normally, C-C binding energy shows itself approximately 284 eV. 39, 40 However, it was proved that chemisorption of carbon over a surface could show its binding energy at 282.6 eV. 41 In addition, amide bond of O=C-N reveals itself at 287.18 eV with a shift and binding energy of 285.8 presents the typical hydrazone linkage (C=N) as detected in previous studies. 42, 43 Furthermore, a small shoulder at 288.5 eV of binding energy shows the RCOO-groups which might come from the Cys residues or non-conjugated carboxyl group over PMAA. In Vitro Drug Release. In addition to the characterization steps, in vitro release profiles of DOX-conjugated polymer coated AuNPs were generated in order to investigate the potential use of these particles as delivery carriers. One of the main characteristic feature of tumor sites is that having the slightly-acidic microenvironment. 45 Therefore, the current study was aimed to generate a pH-sensitive DOX conjugation using the AuNP-PMAA as a vehicle in the use of chemotherapeutic approaches. Many of the pH-sensitive bonds between a drug and a carrier which are formed from a typical hydrazone linkage were evaluated at pH 5.3 as modelling the extracellular pH environment of cancer cells and at pH 7.4 as modelling the environment of healthy cells. 46 As depicted in Figure 6 , free DOX was illustrated the typical release profile at humidified conditions. Up to date, it is known that AuNPs do not have much toxic effect upon 23 both cancer and healthy cell lines as illustrated in our previous works. 47, 48 In this step, AuNP-PMAA structures were initially tested for their influence upon the viability of HeLa cells. Figure 7A represents the effect of polymer coated AuNP particles on cell viability. It can be clearly said that polymer coated AuNPs do not exhibit any toxic effect on HeLa cells up to 500 µg/mL particles (84%). As shown in the Figure 7B , the cell viability profile of free DOX is close to AuNP-PMAA-Cys-DOX up to 1.0 µM DOX (equivalent to 50 µg/mL AuNP-PMAA for conjugate). Although DOX was seemed more effective until 5.0 µM, there was a significant decrease between free DOX (47.11%) and AuNP-PMAA-Cys-DOX (25.6%) in the final concentration (p<0.001). It is known that the delivery of free DOX is based on simple diffusion across the cell membrane. Besides, the uptake of many nanocarriers are based on different endoctyic pathways depending on the cell type and the physicochemical properties of nanocarrier. 49 After the uptake of the functional particles, the particles get cleaved in the cells and therapeutic molecules are delivered in the slightly acidic conditions. Since the in vitro DOX release profile presented the similar behaviour like other studies, the effect of this profile also can give idea for the cytotoxicity. Moreover, it is always showed that free DOX can release easily under acidic conditions in the cumulative drug release profiles. However, the nanocarrier systems get more effective in the 24 h toxicity tests. In our case, we could observe the effective concentration of the proposed theranostic platform as 5.0 µM DOX concentration. Hence, the constructed DOX conjugate with a pH-sensitive bond may be a good potential in the chemotherapy thanks to its sustained release and having a non-toxic carrier architecture. Meanwhile, DOX was applied to cancer cells in a reported work which supports our findings. 52 In the irradiation of 2.5 and 10 Grays, it is shown that the cell viabilities of the samples ranging from citrate capped AuNPs to AuNP-PMAA-Cys-DOX gave similar results.
These results were also compared statistically, however as can be seen from the figure, there is no dramatic change between applied samples for both irradiation doses. Furthermore, the free DOX concentation of 5.0 µM did not present any additional therapeutic effect at 2.5
Gray. The cell viability of that sample is similar to cytotoxicity test. Within the increase of irradiation level, both AuNP-PMAA and DOX created a significant effect according to the control group. As mentioned in introduction part, the radiosensitive effect of AuNPs could demonstrate in this study, clearly. Expectedly, AuNP-PMAA-Cys-DOX particles were able to 
ASSOCIATED CONTENT AUTHOR INFORMATION

